Unlocking the therapeutic potential of macrocycles, advancing prodrug delivery systems
for better patient outcomes.

Theta Therapeutics is a biotech startup originating from university research. We specialize in formulation development for macrocyclic drug candidates aimed at treating rare and intractable diseases.

Macrocyclic drug candidates represent a new class of therapeutics with unique cyclic structures, different from small molecules, nucleic acids, or antibodies. Although they hold great potential in areas such as oncology, their development is often hindered by issues like poor solubility, strong side effects, and inefficient delivery.

Our mission is to address these barriers by creating innovative formulations that preserve therapeutic activity while enhancing solubility, safety, and tolerability.